Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Yanyan Da

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5054631615. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. Histone lactylation increases CXCL1 expression for neutrophil infiltration and immune escape in pancreatic cancer. Co-author DOI 10.1038/s41467-026-69311-5↗
  2. Patient-derived organoids guide personalized therapy for KRAS-mutant pancreatic cancer: synergistic MEK/mTOR inhibition and predictive chemotherapy responses. Co-author DOI 10.3389/fimmu.2026.1760379↗
  3. STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer. Co-author DOI 10.1080/2162402x.2022.2054105↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaorui Wang · 1 shared paper, 2026 · strength 0.29
  2. Jin Yang · 1 shared paper, 2026 · strength 0.29
  3. Peng Zhang · 1 shared paper, 2026 · strength 0.22
  4. Yanfen Ma · 1 shared paper, 2026 · strength 0.22
  5. Chengsheng Zhang · 1 shared paper, 2026 · strength 0.22
  6. Chenxi Li · 1 shared paper, 2026 · strength 0.22
  7. Cai Zhang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.